A comprehensive screening test combining liquid-based cytology (LBC) and highly sensitive molecular detection of high-risk human papillomavirus (HPV) DNA using polymerase chain reaction (PCR). Considered the modern gold standard for early cervical cancer screening, it provides a thorough assessment of both existing cellular changes and the presence of the primary causative virus.